[SMC] Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome
Posté : 09 avr. 2022 12:00
Pediatr Int. 2022 Jan;64(1):e15115. doi: 10.1111/ped.15115.
NO ABSTRACT
PMID:35396808 | DOI:10.1111/ped.15115
Source: https://pubmed.ncbi.nlm.nih.gov/3539680 ... 1&v=2.17.6